|
ESLA Estrella Immunopharma Inc 1844417 |
| Balance Sheet |
|
Current Assets
|
2,235,145 |
|
Assets
|
3,735,145 |
|
Current Liabilities
|
2,988,859 |
|
Liabilities
|
2,988,859 |
|
Equity
|
746,286 |
|
Shares Out
|
36,376,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-2,217,460 |
|
Investing Cash Flow
|
4,960,647 |
| Market Analysis |
Market Cap
|
34,921,237 |
|
Price
|
1.18 |
|
BVPS
|
0.02 |
|
PB
|
57.56 |
|
EPS
|
-1.90 |
|
PS
|
0.20 |
|
FCF
|
2,743,187 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ESLA documents filed with the SEC.
ESLA Filings
Clear
